4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-010060
INTERIM PRESIDENT AND CEO gave up 3,224 shares (to pay taxes)
- INTERIM PRESIDENT AND CEO acquired 9,467 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-04-01 | Option exercise | +9,467 | 1,288,912 | D | ||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-04-01 | Shares withheld for taxes | −3,224 | $1.26 | $4,062 | 1,285,688 | D |
| Derivatives | |||||||
| Walker Neal INTERIM PRESIDENT AND CEO | 2024-04-01 | Option exercise · Restricted Stock Units | −9,467 | 123,067 | D | ||
Loading xslF345X05/form4-04032024_090431.xml…